MYADM antibody (AA 51-150)
Quick Overview for MYADM antibody (AA 51-150) (ABIN6944172)
Target
See all MYADM AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-150
-
Specificity
- This antibody's immunogen sequence has 91 % homology (10/11 residues) with the Rat MYADM protein and is predicted to work with Rat samples
-
Cross-Reactivity
- Human
-
Predicted Reactivity
- Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MYADM
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- MYADM (Myeloid-Associated Differentiation Marker (MYADM))
-
Alternative Name
- MYADM
-
Background
-
Synonyms: MYADM, MYADM_HUMAN, myeloid associated differentiation marker, Myeloid upregulated protein, Myeloid-associated differentiation marker, Protein SB135.
Background: Myeloid-associated differentiation marker (MYADM) is a member of the MAL family with the unique features of having eight transmembrane regions and a ubiquitous pattern of expression and of being found localized at the plasma membrane. MYADM has been found to be associated with the differentiation of hematopoietic cells or acute promyelocytic leukemia cells. MYADM could serve as a new marker for hematopoietic differentiation and is a target for diagnostic, prognostic and/or therapeutic interventions.
-
Gene ID
- 91663
-
UniProt
- Q96S97
Target
-